iRadimed Corporation (IRMD) Social Stream



iRadimed Corporation (IRMD): $43.99

0.62 (+1.43%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

B

IRADIMED CORP (IRMD) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering IRADIMED CORP.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-02-07 1 $53 $53 $53 $44.7 18.57%
2022-05-02 1 $40 $40 $40 $44.7 -10.51%
2022-11-04 1 $42 $42 $42 $44.7 -6.04%
2023-01-20 1 $46 $46 $46 $44.7 2.91%
2023-02-03 1 $48 $48 $48 $44.7 7.38%
2023-05-04 2 $50 $50 $50 $44.7 11.86%
2023-08-03 1 $60 $60 $60 $44.7 34.23%
2023-08-08 2 $60 $55 $57.5 $44.7 28.64%
2023-11-03 2 $60 $56 $58 $44.7 29.75%

The Trend in the Analyst Price Target


IRMD's average price target has moved up $20 over the prior 26 months.

IRMD reports an average of 18.92% for its upside potential over the past 41 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-05-04 1 50 50 50 46.20 8.23%
2023-08-03 2 60 60 60 48.20 24.48%
2023-08-03 1 60 50 55 48.20 14.11%
2023-08-03 1 60 60 60 48.20 24.48%
2023-11-03 2 60 56 58 45.06 28.72%

IRMD Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The Trend in the Broker Recommendations


IRMD's average broker recommendation rating improved by 0 over the prior 18 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for IRMD as an investment opportunity.

  • In the context of all US stocks, IRADIMED CORP's number of analysts covering the stock is greater than 11.32% of them.
  • To contextualize these metrics, consider that out of all US stocks, IRADIMED CORP's variance in analysts' estimates is lower than 74.5% of them.
  • In the context of stocks in the small market cap category, IRADIMED CORP's average analyst price target is higher than 997.75% of them.
  • In the context of stocks in the small market cap category, IRADIMED CORP's upside potential (average analyst target price relative to current price) is higher than 243.61% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Medical Equipment industry with the ratings most similar to IRADIMED CORP are INFU, NURO, and LMAT.

Make investment decisions regarding IRMD using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!